XML 98 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Segment Information
The following tables present certain operations information by reportable segment.
 
 
Life
Sciences
 
Mobile
Solutions
 
Power
Solutions
 
Corporate
and
Consolidations
 
Total
Year Ended December 31, 2019
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
359,732

 
$
297,749

 
$
192,100

 
$
(2,130
)
(a)
$
847,451

Depreciation and amortization
 
46,905

 
27,146

 
15,301

 
2,494

 
91,846

Income (loss) from operations
 
28,157

 
9,553

 
13,881

 
(41,702
)
 
$
9,889

Interest expense
 
 
 
 
 
 
 
 
 
(57,155
)
Other
 
 
 
 
 
 
 
 
 
(4,433
)
Loss before provision for income taxes and share of net income from joint venture
 
 
 
 
 
 
 
 
 
$
(51,699
)
Share of net income from joint venture
 
$

 
$
1,681

 
$

 
$

 
$
1,681

Expenditures for long-lived assets
 
21,445

 
24,969

 
4,457

 
3,132

 
54,003

Total assets
 
811,526

 
373,256

 
310,545

 
46,657

(b)
1,541,984

 
 
Life
Sciences
 
Mobile
Solutions
 
Power
Solutions
 
Corporate
and
Consolidations
 
Total
Year Ended December 31, 2018
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
248,173

 
$
335,037

 
$
189,778

 
$
(2,331
)
(a)
$
770,657

Depreciation and amortization
 
28,091

 
26,217

 
14,753

 
2,067

 
71,128

Goodwill impairment
 

 
73,442

 
109,100

 

 
182,542

Income (loss) from operations
 
19,136

 
(55,079
)
 
(95,115
)
 
(48,806
)
 
$
(179,864
)
Interest expense
 
 
 
 
 
 
 
 
 
(61,243
)
Other
 
 
 
 
 
 
 
 
 
(20,903
)
Loss before benefit for income taxes and share of net income from joint venture
 
 
 
 
 
 
 
 
 
$
(262,010
)
Share of net income from joint venture
 
$

 
$
(14,390
)
 
$

 
$

 
$
(14,390
)
Expenditures for long-lived assets
 
14,645

 
36,660

 
6,459

 
6,272

 
64,036

Total assets
 
802,770

 
354,542

 
297,947

 
45,643

(b)
1,500,902

 
 
Life
Sciences
 
Mobile
Solutions
 
Power
Solutions
 
Corporate
and
Consolidations
 
Total
Year Ended December 31, 2017
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
98,329

 
$
336,852

 
$
186,602

 
$
(1,990
)
(a)
$
619,793

Depreciation and amortization
 
12,088

 
24,491

 
14,657

 
1,170

 
52,406

Income (loss) from operations
 
13,271

 
33,071

 
23,440

 
(38,002
)
 
$
31,780

Interest expense
 
 
 
 
 
 
 
 
 
(52,085
)
Other
 
 
 
 
 
 
 
 
 
(39,902
)
Loss before benefit for income taxes and share of net income from joint venture
 
 
 
 
 
 
 
 
 
$
(60,207
)
Share of net income from joint venture
 
$

 
$
5,211

 
$

 
$

 
$
5,211

Expenditures for long-lived assets
 

 
24,056

 
5,443

 
6,907

 
36,406

Total assets
 
353,208

 
427,027

 
385,558

 
307,916

 
1,473,709

_______________________________
(a) Includes eliminations of intersegment transactions which occur during the ordinary course of business.
(b) Total assets in Mobile Solutions includes $21.8 million and $20.4 million as of December 31, 2019 and 2018, respectively, related to the investment in our 49% owned joint venture (Note 11).
The following table summarizes the net sales and income (loss) from operations from acquisitions in the Life Sciences and Power Solutions groups for the years ended December 31, 2018 and 2017.
 
 
Year Ended December 31,
 
 
2018
 
2017
Net sales
 
 
 
 
Paragon Medical
 
$
116,998

 
$

Other
 
42,636

 
6,682

 
 
 
 
 
Income (loss) from operations
 
 
 
 
Paragon Medical
 
$
8,086

 
$

Other
 
1,816

 
(458
)
Summary of Sales to External Customers and Long-Lived Tangible Assets by Geographical Region
The following table summarizes long-lived tangible assets by geographical region.
 
 
Property, Plant, and Equipment, Net
As of December 31,
 
 
2019
 
2018
United States
 
$
250,163

 
$
235,975

Europe
 
54,829

 
50,143

Asia
 
43,128

 
42,657

Mexico
 
1,388

 
7,647

S. America
 
25,005

 
24,606

All foreign countries
 
$
124,350

 
$
125,053

Total
 
$
374,513

 
$
361,028